The effect of preventative cardiovascular therapies on coronary artery disease in people with and without type 2 diabetes: A propensity-matched score study
BMC Cardiovascular Disorders Oct 03, 2021
Kiburg KV, MacIsaac AI, McCluskey GE, et al. - A greater extent of coronary artery disease (CAD) was found in patients with diabetes vs those without Type 2 Diabetes Mellitus (T2DM), but this CAD burden was significantly reduced by preventative medication use.
From a coronary angiography database, 1,421 patients with T2DM and 1,421 without T2DM were matched on propensity score.
More extensive CAD in T2DM patients was seen in 2018 relative to 2013 ((adjusted odds ratio) adjOR: 2.06 95% C.I. 1.38, 2.07), but this risk seemed to be decreased in 2019.
Significantly higher use of medications was evident in T2DM cases vs patients without diabetes [statins used by 69.8% vs 46.6%, renin-angiotensin system (RAS) inhibitors: 64.0% vs 49.0%, and anti-platelet drugs: 64.0% vs 49.9%].
As in the full matched sample, more extensive CAD was found in patients with diabetes (adjOR: 1.32).
However, post-adjustment for use of RAS inhibitors, statins and anticoagulants, extent of CAD did not differ between patients with and without diabetes (adjOR: 1.14).
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries